Tuesday, January 8, 2008

View Of Liver Tumors Sharpened By High-Energy Ultrasound

A high-energy form of ultrasound imaging developed by researchers at Duke University's Pratt School of Engineering produces pictures of liver tumors that are better than those made with traditional ultrasound, according to results of a clinical study.

The study suggests that the imaging method known as Acoustic Radiation Force Impulse (ARFI) ultrasound might offer a new tool for screening patients at increased risk for liver cancers, according to the researchers. They say it might also play a useful role in guiding biopsy procedures and minimally invasive therapies aimed at destroying cancerous tissues found deep in the abdomen.

MedicalNewsToday

Monday, January 7, 2008

Three-D sonography used to detect bladder tumors proves promising

Three-D ultrasound examination shows the location, size, and perivesical spreading of bladder tumors just as well as conventional cystoscopy. The technique has the advantage of being noninvasive.

Bladder cancer is the fourth most common cancer in men in the U.S. and the 10th most common in women. It usually occurs in patients over 68 years of age, so a noninvasive way to evaluate cases in elderly patients could lower risks of complications.

Diagnostic Imaging

Friday, January 4, 2008

Escalon(R) Announces FDA 510(k) Clearance For Sonomed MASTER-VU(TM) B-Scan System

Escalon Medical Corp. (Nasdaq Capital Market: ESMC) announced that its Sonomed, Inc. subsidiary received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the MASTER-VU(TM) ophthalmic B scan ultrasound system. The MASTER-VU(TM) System consists of a B scan probe that can be interfaced to a standard personal computer (via a USB cable connection) using Sonomed's proprietary software, thereby converting the personal computer into an ophthalmic ultrasound system. Sonomed plans to commence shipments of the product in the United States immediately.

Barry Durante, Sonomed's President stated: "The FDA clearance, along with the previously received CE certification, will allow Sonomed to market this new breakthrough instrumentation worldwide. With computers becoming standard in most ophthalmic physician offices, purchasing the probe and software offers complete portability for use in multiple locations. Loading the software in computers in multiple offices allows the physician to carry only the probe from office to office. We expect that the MASTER-VU(TM) will be a valuable addition to our product line in both the U.S. and international marketplace."

MedicalNewsToday

Friday, December 28, 2007

Ultrasound fails to spot ovarian cancer

Annual screening with a technique called transvaginal ultrasound, coupled with a blood test for CA125, a protein that can be elevated in the setting of ovarian cancer, does not reliably detect ovarian cancer early, at a more curable stage, according to a new study.

"We and other groups confirm that the current method of ovarian screening, which is a combination of ultrasound scans and (blood) markers, is ineffective," Dr Emma R Woodward from Birmingham Women's Hospital, UK, told Reuters Health.

"Therefore, for women at high risk of developing ovarian cancer, the only real option at present to prevent ovarian cancer death is to have the ovaries removed as a preventive measure."

source

SonoSite Begins Customer Shipments Of S Series Point-Of-Care Ultrasound Tools

SonoSite, Inc. (Nasdaq:SONO), the world leader in point-of-care, hand-carried ultrasound, announced that it has begun worldwide shipments of its S Series ultrasound tools. Based on the company's fourth generation technology platform, the S Series product line combines the processing power, image quality and advanced data management features of SonoSite's newly introduced M-Turbo™ system with a customized user interface to address the specific needs of four clinical specialties.

"SonoSite is the only company that has designed a system that can withstand rigorous use in the Intensive Care Unit (ICU)," said John M. Oropello, MD, FCCP, FCCM, Professor of Surgery and Medicine, Program Director, Critical Care Medicine and Co-Director, Neurosurgical - ICU, Mount Sinai School of Medicine, New York. "We evaluated a lot of machines and no one else has taken into account what critical care physicians need. Both the S-ICU and M-Turbo have superb image quality and are easy to clean-so essential to infection control. I can foresee the day when there will be an S ultrasound tool mounted by every bedside in the ICU."

source

Saturday, December 22, 2007

ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20

MOUNTAIN VIEW, Calif., Dec. 20 /PRNewswire/ -- ZONARE Medical Systems, a developer of premium ultrasound systems, today announced it has been ranked Best in KLAS as the top hand carried ultrasound (HCU) vendor in the KLAS Top20: Year-End Report published this week. Previously, the company was ranked number one in the inaugural HCU KLAS study. KLAS, a highly respected research firm specializing in monitoring and reporting the performance of information technology and medical imaging vendors in the healthcare field, continued several studies to incorporate additional customer data in order to determine Best in KLAS for 20 different categories for the year, including the HCU market.

press release

Monday, December 10, 2007

GE Healthcare Licenses Rights To Ultrasound Diagnostic Protocol Developed By Eastern Virginia Medical School Obstetrician

GE Healthcare, a leading manufacturer of 3D/4D ultrasound systems, has licensed a technique patented by an Eastern Virginia Medical School (EVMS) obstetrician that can automate the acquisition of ultrasound images used by physicians to diagnose fetal heart defects. GE Healthcare has licensed the software for exclusive use in its 3D/4D ultrasound systems.

Alfred Abuhamad, M.D., chairman of obstetrics and gynecology at EVMS - recognized worldwide for his skills in using ultrasound to detect fetal heart defects - developed the automation protocol, called Sonography based Volume Computer Aided Diagnosis (SonoVCAD).

source

Friday, December 7, 2007

Toshiba And TomTec Deliver New Tools For Cardiac 4D Ultrasound

Toshiba Medical Systems Corporation and TomTec Imaging Systems GmbH announced an agreement to deliver new tools for assessing cardiac 4D data and a collaboration to make them more widely available at EuroEcho which is held from December 5th to 8th in Lisbon, Portugal. With the recent announcement of Toshiba's ArtidaTM Cardiac 4D Ultrasound System, a variety of new 4D capabilities were released. TomTec diagnostic workstations will be able to read Artida's data providing increased customer options for image review and a host of new advanced applications.

"We designed Artida to be the first of a new generation of the cardiac 4D ultrasound systems." said Hiroyuki Tsujino, General Manager, Ultrasound Systems Division at Toshiba Medical Systems Corporation. "This is why we developed the smallest and lightest 4D transducers together with the SmartCore technology to generate precise 4D images quickly. To provide a total workflow solution to the customer, TomTec was a natural choice for the image review and analysis. We admire TomTec for its long-standing commitment to innovation in diagnostic ultrasound"

source

Tuesday, December 4, 2007

New Research Reveals Ultrasound Treatment Of Benefit To Prostate Cancer Sufferers

First analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer (European Journal of Urology online).

Prostate cancer experts say high intensity focussed ultrasound (HIFU) is an effective treatment option for men with prostate cancer, according to new research published this month in the European Journal of Urology online.

Experts from France and Germany studied the results of 140 people with prostate cancer over an eight year period and published their findings in the EJU.

source

Friday, November 23, 2007

Ultrasound may Better Classify Ovarian Tumors

Experts examining patterns in ultrasound images can more accurately classify ovarian tumors as benign or malignant than can pre-surgical blood tests, according to a study published online in the Nov. 13 Journal of the National Cancer Institute.

An elevated level of the protein CA-125 in blood is considered an indicator of whether an ovarian tumor is benign or malignant. This measure, however, can often be inaccurate.

Another option is an ultrasound examination of the tumor. An experienced ultrasound examiner can often accurately classify an ovarian tumor using a method of pattern recognition.

source article

Advanced Elastography Features Available on HI VISION(TM) 900 Premium Ultrasound System

Hitachi Medical Systems America anticipates a surge of excitement within the ultrasound community, when more than ten live sessions and written posters evaluating the emerging technique of ultrasound elastography are presented at this year's Scientific Meeting of the Radiological Society of North America.

Elastography is rooted in the practice of palpation, one of the oldest concepts in medicine. When an abnormal mass is discovered in a patient, an important aspect of the initial clinical examination is physically palpating the mass to assess its stiffness. Hitachi's Elastography takes this concept one step further by using ultrasound to perform sophisticated and sensitive measurements of relative stiffness and creating detailed images depicting this information.

source

Wednesday, November 21, 2007

Through-Wave Ultrasound: Effective, Economical and Ideal for Breast Imaging, Biopsy

RICHLAND, Wash., Nov. 20 /PRNewswire/ -- Advanced Imaging Technologies,
today announced the ARIA Breast Imaging System (BIS),a real-time through-wave ultrasound imaging system that uses the diffractiveproperties of sound combined with holography (HU) to create highly-detailed,three-dimensional images of breast tissue, is now equipped for image-guidedbiopsy. The automated system has clinically proven to provide superior viewsof the breast tissue, especially dense tissue, while delivering better datafor enhanced diagnostic decision-making. The system's image-guidance for
biopsy will be demonstrated in booth #2179 at the Radiological Society of North America (RSNA) Scientific Sessions November 25-29, 2007 in Chicago.

source

Wednesday, November 14, 2007

Siemens Introduces The World's Smallest Ultrasound Unit For Emergency Diagnostics

The first few minutes are often the deciding factor in emergency situations. For this reason, Siemens is now offering a mini ultrasound unit that will enable patients to receive medical treatment faster than ever before. Because this unit is just as compact as a PDA cell phone, weighs only about 700 grams, and easily fits into the physician's pocket. It is thus especially suitable for emergency medical applications, i.e. examining injuries on site in order to ensure that each patient receives the medical treatment he requires.

The "Acuson P10" mini ultrasound unit offers decisive advantages for first aid in outpatient areas, rescue helicopters and intensive care units: It is mobile, easy to operate and available to physicians whenever and wherever it is needed. When set to high-definition ultrasound image acquisition, it can, for example, be used to detect accumulations of liquids in the body and heart action, display any damage to arteries and examine the pelvis. In obstetrics, this mini ultrasound unit can be used even during childbirth to determine the unborn child's location, chances of survival and position, as well as to visualize the amount of amniotic fluid or bleeding and their tendency to escape in due time.


MedicalNewsToday

Tuesday, November 13, 2007

MEDISON Launches New Ultrasound System: ACCUVIX V10

The advanced ultrasound system ACCUVIX XQ has been widely recognised worldwide for its advanced technology and stability, but a new unit is about to steal its thunder.

Produced by South Korea-based MEDISON Co Ltd (CEO: J. B. Choi) ACCUVIX XQ was ranked, according to the Klein Report, in second place in the number of units sold in 2005 as well as 2006 in the US$200 million American obstetrics and gynaecology ultrasound market. However, the XQ has now been superseded by the latest in the line: the ACCUVIX V10.

source article

Friday, November 9, 2007

Screening for Abdominal Aortic Aneurysms in Women May Save Lives

Newswise — In 9 out of 10 cases, a burst abdominal aortic artery is quickly fatal for its most common victim: elderly males. A new study -- the largest yet performed -- now confirms that women over 65 with a history of smoking or heart disease are also at high risk for an abdominal aortic aneurysm (AAA) -- supporting the notion that they should also receive ultrasound screening to help spot and correct the dangerous condition.

The findings, reported in the Journal of Vascular Surgery, challenge current recommendations on AAA screening issued by the United States Preventive Services Task Force. Those guidelines recommend that screening only be performed -- and reimbursed by Medicare -- for men aged 65 to 75 who have ever smoked.


source

Tuesday, November 6, 2007

GE Breakthroughs Seek To Re-Invent Cardiovascular Ultrasound

Ultra Definition: True 4D Echo
The Vivid 7 Dimension '08

One has been given the gift of enhanced, crystal-clear sight. The other gets a three-connector docking cart, stress echo and an ergonomic work over. GE Healthcare, the global ultrasound leader, launched two breakthroughs for its popular Vivid e and Vivid 7 Dimension cardiovascular ultrasound systems at this year's meeting of the American Heart Association in Orlando, FL. Building upon GE's successful introduction of Vivid products in 2000, GE continues to bring to market innovative, high-performance cardiovascular ultrasound systems.

source